Elizabeth Pisani
Overview
Explore the profile of Elizabeth Pisani including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
406
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pisani E, Rahmawati A, Mulatsari E, Rahmi M, Nathanial W, Anggriani Y
PLOS Glob Public Health
. 2024 Dec;
4(12):e0003999.
PMID: 39666666
The World Health Organization warns that substandard and falsified medicines threaten public health in low- and middle-income countries. However, medicine quality surveys are often small and unrepresentative of the market,...
2.
Valente de Almeida S, Hauck K, Njenga S, Nugrahani Y, Rahmawati A, Mawaddati R, et al.
BMJ Glob Health
. 2024 Sep;
9(9).
PMID: 39313254
Background: Substandard and falsified medicines (SFMs) are a public health concern of global importance. Postmarket surveillance in the form of medicine sampling and quality testing can prevent and detect SFM,...
3.
Pisani E, Dewi A, Palagyi A, Praveen D, Pratita Ihsan B, Lawuningtyas Hariadini A, et al.
Am J Trop Med Hyg
. 2023 May;
108(6):1287-1299.
PMID: 37160275
Lower-middle income Indonesia, the world's fourth most populous country, has struggled to contain costs in its mandatory, single-payer public health insurance system since the system's inception in 2014. Public procurement...
4.
Dewi A, Pisani E, Pratita Ihsan B, Lawuningtyas Hariadini A, Patel A, Palagyi A, et al.
J Pharm Policy Pract
. 2023 Mar;
16(1):50.
PMID: 36949533
Background: In Indonesia, the world's fourth most populous country, cardiovascular diseases (CVDs) are a leading cause of death and disability. Government efforts to reduce the burden of CVD include a...
5.
Nistor A, Pisani E, Kok M
BMJ Glob Health
. 2023 Feb;
6(Suppl 3).
PMID: 36731920
Introduction: To protect patients against falsified medicines, countries around the world implement stringent regulations. Despite efforts to protect supply chains in the European Union (EU), authorities continue to find falsified...
6.
Dewi A, Patel A, Palagyi A, Praveen D, Pratita Ihsan B, Lawuningtyas Hariadini A, et al.
BMJ Glob Health
. 2022 Nov;
7(11).
PMID: 36427901
Background: The WHO has warned that substandard and falsified medicines threaten health, especially in low and middle-income countries (LMICs). However, the magnitude of that threat for many medicines in different...
7.
Almoteiry K, Alharf A, Al Hammad B, Aljuffali I, Al-Azemi N, Al-Ghaith T, et al.
Bull World Health Organ
. 2022 Aug;
100(8):511-519.
PMID: 35923275
Medicines are at the core of every health system. The World Health Organization recommends countries develop national medicines policies that guide production, procurement, prescription and provision of medicines so that...
8.
A systematic review of pooled procurement of medicines and vaccines: identifying elements of success
Parmaksiz K, Pisani E, Bal R, Kok M
Global Health
. 2022 Jun;
18(1):59.
PMID: 35690779
Introduction: Pooled procurement of health commodities has increasingly been promoted as a solution to reduce prices, increase availability, and achieve more efficient procurement processes. However, little is known about what...
9.
Pratiwi A, Setiyaningsih H, Kok M, Hoekstra T, Mukti A, Pisani E
BMJ Open
. 2021 Oct;
11(10):e050565.
PMID: 34607864
Objectives: To analyse the relationship between health need, insurance coverage, health service availability, service use, insurance claims and out-of-pocket spending on health across Indonesia. Design: Secondary analysis of nationally representative...
10.
Pisani E, Hasnida A, Rahmi M, Kok M, Harsono S, Anggriani Y
JMIR Public Health Surveill
. 2021 Jun;
7(8):e29309.
PMID: 34181563
The World Health Organization and others warn that substandard and falsified medicines harm health and waste money, especially in low- and middle-income countries. However, no country has measured the market-wide...